Pharma, Life Sciences & Medtech — Business MegaBrands 2026–27

Branded and export formulations, APIs, contract development and manufacturing, clinical research, vaccines, biologics, medical devices and diagnostics. India supplies medicine to the world; this sector shows who makes it.

6 industries · 18 categories · 93 brands in contention

Pharmaceuticals

• Branded formulations — large — 8 brands. Branded formulations covers prescription medicines and over-the-counter products sold under brand names to doctors, pharmacies and hospitals across India, made in finished dosage forms such as tablets, capsules, injectables and inhalers.
• Branded formulations — mid-size — 6 brands. Mid-size branded formulations covers pharmaceutical companies that market prescription medicines under brand names in India, often focused on therapy areas such as cardiology, dermatology, pain management, anti-infectives or anti-malarials, and that export to emerging and regulated markets.
• Branded formulations — specialty and challengers — 5 brands. Specialty and challenger branded formulations in India are prescription medicines sold under company brand names, often in chronic therapies such as diabetes, cardiology, dermatology and gynaecology, and promoted to doctors through field teams.
• Export and regulated-market generics — large — 4 brands. This category covers Indian pharmaceutical companies that develop, file and manufacture generic medicines at scale for regulated markets such as the United States, Europe and Japan, alongside sales at home.
• Export generics — mid-size — 5 brands. Mid-size export generics companies manufacture off-patent medicines in India for overseas buyers, typically concentrating on selected therapy areas, niche molecules or emerging markets in Africa, Latin America and Asia.

APIs

• APIs and intermediates — large — 7 brands. Active pharmaceutical ingredients (APIs) are the chemical substances that give a medicine its therapeutic effect, and intermediates are the compounds from which they are synthesised.
• Specialty and fermentation APIs — 6 brands. This category covers Indian manufacturers of complex active pharmaceutical ingredients, including those made by fermentation, high-potency oncology compounds, contrast media and immunosuppressants.
• Generic APIs — mid-size — 5 brands. Mid-size generic API manufacturers in India produce established active pharmaceutical ingredients, such as analgesics, anti-infectives and cardiovascular molecules, for domestic formulators and export customers.

Contract Development & Research

• CDMO and contract research — large — 7 brands. Contract development and manufacturing organisations (CDMOs) and contract research organisations carry out drug discovery, process development, and clinical-scale and commercial manufacturing on behalf of pharmaceutical and biotech clients.
• Formulation contract manufacturing — 3 brands. Formulation contract manufacturers produce finished medicines, such as tablets, capsules, syrups and injectables, which other pharmaceutical companies then sell under their own brands.
• Clinical and discovery research — 3 brands. This category covers Indian contract research organisations that run early-stage drug discovery chemistry and biology, bioavailability and bioequivalence studies, and clinical trials for pharmaceutical companies.

Biologics & Vaccines

• Biologics and biosimilars — 4 brands. Biologics are medicines produced in living cells, such as monoclonal antibodies, insulins and plasma-derived therapies; biosimilars are close equivalents of biologics whose patents have expired.
• Vaccines — 5 brands. Indian vaccine manufacturers develop and produce vaccines for routine childhood immunisation, outbreak response and adult use, supplying the national immunisation effort, private healthcare and international agencies.

Medical Technology

• Cardiac, orthopaedic and surgical implants — 5 brands. This category covers Indian manufacturers of implantable medical devices, including coronary stents, heart valves, orthopaedic joints and trauma implants, and surgical products such as sutures and staplers.
• Medical consumables and disposables — 6 brands. Medical consumables and disposables are single-use products such as syringes, needles, catheters, IV cannulae, blood bags, gloves and wound-care items used in hospitals, clinics and laboratories.
• Medical equipment, imaging and critical care — 5 brands. This category covers Indian makers of medical equipment, including patient monitors, X-ray and imaging systems, ventilators, ophthalmic instruments and other critical-care devices.
• In-vitro diagnostics — 6 brands. In-vitro diagnostics are the tests, reagents, analysers and kits used to examine blood, tissue and other samples outside the body, from routine biochemistry to molecular tests for infectious disease.

Healthcare Supply Chain

• Pharma distribution and hospital procurement — 3 brands. Pharma distribution and hospital procurement companies move medicines, consumables and equipment from manufacturers to pharmacies, hospitals and clinics, increasingly through technology platforms that handle ordering, credit and inventory.

How these brands are evaluated

Every brand in this sector is assessed on WCRC's 50-parameter brand evaluation model, across five weighted pillars. Scores are compared within each category, and one Business MegaBrand is named in each. Read the methodology

WCRC network: WCRC International · WCRC Leaders